Daewon Pharmaceutical Co. Ltd. (003220) — Net Asset Quality Index
Daewon Pharmaceutical Co. Ltd. (003220) has a Net Asset Quality Index of 48.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩573.33 Billion minus total liabilities of ₩297.60 Billion yields net assets of ₩275.73 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 003220 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Daewon Pharmaceutical Co. Ltd. Net Asset Quality Index Over Time (2011–2025)
This chart shows how Daewon Pharmaceutical Co. Ltd.'s Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the index stands at 48.1%, representing net assets of ₩275.73 Billion against total assets of ₩573.33 Billion KRW. See 003220 net asset value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Daewon Pharmaceutical Co. Ltd. (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Daewon Pharmaceutical Co. Ltd. from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Daewon Pharmaceutical Co. Ltd..
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 44.7% | ₩274.58 Billion | ₩613.65 Billion | ₩339.07 Billion | ▼ -4.0 pp |
| 2024 | 48.8% | ₩284.58 Billion | ₩583.39 Billion | ₩298.81 Billion | ▼ -3.2 pp |
| 2023 | 52.0% | ₩264.26 Billion | ₩508.00 Billion | ₩243.73 Billion | ▼ -2.8 pp |
| 2022 | 54.8% | ₩248.77 Billion | ₩453.55 Billion | ₩204.78 Billion | ▲ +4.0 pp |
| 2021 | 50.8% | ₩218.40 Billion | ₩429.58 Billion | ₩211.18 Billion | ▼ -12.6 pp |
| 2020 | 63.5% | ₩212.77 Billion | ₩335.21 Billion | ₩122.44 Billion | ▲ +1.1 pp |
| 2019 | 62.3% | ₩204.22 Billion | ₩327.53 Billion | ₩123.32 Billion | ▼ -4.2 pp |
| 2018 | 66.5% | ₩183.20 Billion | ₩275.44 Billion | ₩92.24 Billion | ▼ -7.5 pp |
| 2017 | 74.0% | ₩168.13 Billion | ₩227.20 Billion | ₩59.07 Billion | ▼ -1.5 pp |
| 2016 | 75.5% | ₩162.01 Billion | ₩214.68 Billion | ₩52.67 Billion | ▼ -0.9 pp |
| 2015 | 76.3% | ₩148.66 Billion | ₩194.75 Billion | ₩46.09 Billion | ▲ +1.9 pp |
| 2014 | 74.5% | ₩134.51 Billion | ₩180.62 Billion | ₩46.11 Billion | ▼ -2.5 pp |
| 2013 | 77.0% | ₩123.25 Billion | ₩160.14 Billion | ₩36.89 Billion | ▲ +0.2 pp |
| 2012 | 76.8% | ₩112.92 Billion | ₩147.13 Billion | ₩34.20 Billion | ▲ +2.7 pp |
| 2011 | 74.0% | ₩103.92 Billion | ₩140.39 Billion | ₩36.47 Billion | — |